Compare T-Rex 2X Long MSTR Daily Target ETF (MSTU) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T-Rex 2X Long MSTR Daily Target ETF vs Recursion Pharmaceuticals Inc — how do they compare? T-Rex 2X Long MSTR Daily Target ETF trades at $2.14, while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). Which is the better fit depends on your goals.
| MSTU | RXRX | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $92.70 | $6.79 |
52-Week Low | $1.46 | $2.84 |
Market Cap | — | $1.53B |
Enterprise Value | — | $946.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
